Overview
Updated 14 Jul 2026
Syma Iqbal, MD, is General Practitioner at The Quay Family Healthcare, Torquay VIC (formerly Registrar, University Hospital Geelong / Barwon Health). The public record shows 185 publications with 4,516 citations (h-index 34), centered on Bladder / Urothelial Cancer, Hepatobiliary Cancer, Gastroesophageal Cancer. It also documents an investigator role on 23 registered clinical trials, industry payments reported by 10 companies, 2 NIH-funded awards (2006–2026).
- Most recent indexed publication: 2018 · Journal of surgical case reports
- Top research focus: Bladder / Urothelial Cancer
- 23 registered trials on ClinicalTrials.gov
- Open Payments reporting from 10 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 23 registered studies on ClinicalTrials.gov. The most recent:
- Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Sponsor: National Cancer Institute (NCI)
InvestigatorPhase 2/PHASE3RecruitingNCT06203600 - mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Sponsor: Alliance for Clinical Trials in Oncology
InvestigatorPhase 3RecruitingNCT05677490 - Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Sponsor: SWOG Cancer Research Network
InvestigatorPhase 2RecruitingNCT05040360
Industry payments
Updated 14 Jul 2026
10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Astellas Pharma US IncProgram year202522 payments$36,355openpaymentsdata.cms.gov ↗
- BeOne Medicines USA, Inc.Program year20258 payments$14,342openpaymentsdata.cms.gov ↗
- BeiGene USA, Inc.Program year20252 payments
NIH funding
Updated 14 Jul 2026
2 NIH research awards on record, funded 2006–2026 per NIH RePORTER. The latest:
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tqfhc.com.au ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tqfhc.com.au ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tqfhc.com.au ↗
Secondary affiliationsappointments beyond the home institution
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tqfhc.com.au ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by otherswhere others cite or feature them
- LinkedIn
LinkedIn: "surgical registrar at Barwon Health" (au.linkedin.com/in/syma-iqbal-355b4b186)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →au.linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
- 1,431
- publications
- 164
- h-index
- 8
- trials
Toni Choueiri, MD
Brigham and Women's Hospital
- 2,494
- publications
- 152
- h-index
- 12
- trials
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
- 1,588
- publications
- 150
- h-index
- 18
- trials
Fred Saad, MD
Centre Hospitalier de l’Université de Montréal
- 1,915
- publications
- 128
- h-index
- 7
- trials